Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of how prolactin travels to gene’s machinery helps explain its role in breast cancer

14.04.2003


Prolactin, a naturally occurring peptide hormone needed for milk production following pregnancy, has been found to play a major role in the development and spread of breast cancer. More recently, Dr. Charles Clevenger, the same researcher who first demonstrated the scope and mechanism of prolactin’s role in cancer, has discovered that prolactin functions directly inside the cell, not merely by sending signals across the cell membrane as had been assumed for it and all other peptide hormones.



Dr. Clevenger also has discovered how prolactin is able to travel across the cell membrane and directly into the DNA machinery of the cell. These findings suggest a pathway through which new therapies could block the growth and spread of breast cancer -- and offer a new paradigm for how other hormones function, not just in breast cancer but in a number of other diseases.

The University of Pennsylvania researcher describes his research at the Experimental Biology 2003 meetings in San Diego. He will be honored by the American Society of Investigative Pathology, at the EB 2003 meeting, with the Pfizer Outstanding Investigator Award. The award honors a decade of steady unraveling, by Dr. Clevenger, of how prolactin works in breast cancer, including this most recent discovery.


Although scientists recognized prolactin was involved with breast cancer in rats as early as the 1970s, they focused solely on the hormone produced by the pituitary gland in the brain. Human trials based on this assumption failed miserably. But in the 1990s, using greatly improved technology and techniques, Dr. Clevenger was able to show that breast tissue itself produces prolactin in significant quantities and that more than 95 percent of all breast cancers express the prolactin receptor, meaning prolactin was active in the tumors. At the same time, a large population study of nurses had found that women with higher levels of prolactin were at greater risk for breast cancer.

Soon thereafter, Dr. Clevenger was able to show how prolactin organized the breast cancer cells to move from the breast to other parts of the body.

His most recent discovery is how prolactin is able to get to the DNA of the cell and what it does there. For years, scientists assumed that as a peptide protein, prolactin worked from a distance, outside the cell (unlike steroid hormones which have the ability to leap across the cell membrane on their own, without any help). And indeed, prolactin does work outside the cell. It binds to prolactin receptors, proteins found at the surface of breast cells. When prolactin locks into the receptors, these receptors send out signals that activate genes to stimulate the production of proteins necessary for either milk production in normal breast cells or cancerous growth and spread in malignant ones.

But Dr. Clevenger did not believe this was the only way prolactin worked. Using breast cancer cells in a petri dish, he showed that prolactin is able to physically enter the cell, travel straight to the cell’s DNA, and directly activate the process that turns on genes and triggers the growth of breast cancer cells. It does this by binding to a protein called cyclophilin B, or CYPB for short. This protein serves as the chaperone (a scientific term as well as a very good descriptor) across the cell membrane and into the DNA. CYPB also is an active partner in turning on the genes critical in the development of cancer.

This is exciting news, says Dr. Clevenger. It means we can target drugs to particular tissues in ways not possible before. His own laboratory has applied mutant forms of the CYPB protein to breast cancer cells in vitro and found that breast cancer cells die and normal cells don’t. He says, "When scientists began to understand the implications of the hormone estrogen on breast cancer, it became possible to develop drugs to combat estrogen’s role. When it comes to combating the role of prolactin in breast cancer, we’re 10 years behind where we are with tamoxifen therapy. But then, with advances in science, what once took 10 years may now only take five years."

The discovery of how prolactin enters the cellular DNA is also exciting because "there is a larger message here than breast cancer," according to Dr. Clevenger. Other laboratories are finding other peptide hormones that wind up in the nucleus: hormones like epidermal growth factor, growth hormone, insulin. They haven’t yet found the mechanism similar to the chaperone protein that works for prolactin, but Dr. Clevenger hopes his findings will provide new therapies for other malignancies and diseases such as diabetes.

Sarah Goodwin | EurekAlert!
Further information:
http://www.faseb.org/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>